PMS30 EFFECTS OF 12-HOUR, EXTENDED-RELEASE HYDROCODONE/ACETAMINOPHEN ON PAIN-RELATED WORK PRODUCTIVITY: A SUBANALYSIS FROM A 56-WEEK OPEN-LABEL STUDY

D Webster; D Herrington; B Corser; R Rapoport; AH Dikranian; JW Thomas; PG Vo; SE Marx; AE Best; R Jain

doi:10.1016/s1098-3015(10)70832-9

PMS30 EFFECTS OF 12-HOUR, EXTENDED-RELEASE HYDROCODONE/ACETAMINOPHEN ON PAIN-RELATED WORK PRODUCTIVITY: A SUBANALYSIS FROM A 56-WEEK OPEN-LABEL STUDY

Value in Health ◽

10.1016/s1098-3015(10)70832-9 ◽

2008 ◽

Vol 11 (3) ◽

pp. A263-A264

Author(s):

D Webster ◽

D Herrington ◽

B Corser ◽

R Rapoport ◽

AH Dikranian ◽

...

Keyword(s):

Extended Release ◽

Work Productivity ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

An Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future Research on Doxazosin

FOCUS The Journal of Lifelong Learning in Psychiatry ◽

10.1176/appi.focus.20170031 ◽

2018 ◽

Vol 16 (1) ◽

pp. 67-73 ◽

Cited By ~ 2

Author(s):

Anne Richards ◽

Sabra Inslicht ◽

Leslie Micaela Ruoff ◽

Thomas James Metzler ◽

Lizabeth Alexandra Goldstein ◽

...

Keyword(s):

Extended Release ◽

Future Research ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2019.02.570 ◽

2019 ◽

Vol 27 ◽

pp. S505-S506

Author(s):

A. Gomoll ◽

A. Spitzer ◽

J.C. Richmond ◽

V.B. Kraus ◽

D.G. Jones ◽

...

Keyword(s):

Triamcinolone Acetonide ◽

Extended Release ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Repeat Administration

Download Full-text

Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.116625 ◽

2020 ◽

Vol 410 ◽

pp. 116625 ◽

Cited By ~ 2

Author(s):

Livia Brusa ◽

Viviana Ponzo ◽

Alessandro Stefani ◽

Roberto Ceravolo ◽

Giovanni Palermo ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

An Open-Label Study of Guanfacine Extended Release for Traumatic Stress Related Symptoms in Children and Adolescents

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2012.0119 ◽

2013 ◽

Vol 23 (4) ◽

pp. 244-251 ◽

Cited By ~ 50

Author(s):

Daniel F. Connor ◽

Damion J. Grasso ◽

Michelle D. Slivinsky ◽

Geraldine S. Pearson ◽

Alok Banga

Keyword(s):

Children And Adolescents ◽

Traumatic Stress ◽

Extended Release ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide

Journal of Pain Research ◽

10.2147/jpr.s82395 ◽

2015 ◽

pp. 347

Author(s):

Vardit Dror ◽

Beatrice Setnik ◽

Carl Roland ◽

Kenneth Sommerville ◽

Glenn Pixton ◽

...

Keyword(s):

Primary Care ◽

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Naltrexone Hydrochloride

Download Full-text

Editorial Comment on: Long-Term Tolerability of Tolterodine Extended Release in Children 5–11 Years of Age: Results from a 12-Month, Open-Label Study

European Urology ◽

10.1016/j.eururo.2007.05.003 ◽

2007 ◽

Vol 52 (5) ◽

pp. 1516-1517

Author(s):

Maximilian Burger

Keyword(s):

Editorial Comment ◽

Extended Release ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Term Tolerability

Download Full-text

The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population

BMC Psychiatry ◽

10.1186/s12888-014-0378-5 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 30

Author(s):

Pei-Yin Pan ◽

Meei-Shyuan Lee ◽

Chin-Bin Yeh

Keyword(s):

Chinese Population ◽

Extended Release ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Open Label Study ◽

Label Study

Download Full-text

Pharmacokinetics of dalfampridine extended release 7.5‐mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open‐label study

The Journal of Clinical Pharmacology ◽

10.1002/jcph.189 ◽

2013 ◽

Vol 54 (1) ◽

pp. 53-60 ◽

Cited By ~ 5

Author(s):

Emil Samara ◽

Peter Winkle ◽

Patricia Pardo ◽

Herbert R. Henney ◽

Susan L. Way ◽

...

Keyword(s):

Renal Impairment ◽

Healthy Subjects ◽

Extended Release ◽

Moderate Renal Impairment ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A single-center, open-label study to assess change in psychosocial and occupational dimensions with ustekinumab treatment of moderate to severe psoriasis evaluated with the Psychological General Well Being (PGWB), work productivity, and activity impairment

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.679 ◽

2014 ◽

Vol 70 (5) ◽

pp. AB163

Keyword(s):

Work Productivity ◽

Well Being ◽

Severe Psoriasis ◽

Single Center ◽

Open Label ◽

Activity Impairment ◽

Open Label Study ◽

Label Study

Download Full-text

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence

Journal of Addiction Medicine ◽

10.1097/adm.0000000000000302 ◽

2017 ◽

Vol 11 (3) ◽

pp. 224-230 ◽

Cited By ~ 10

Author(s):

Paul H. Earley ◽

Jacqueline Zummo ◽

Asli Memisoglu ◽

Bernard L. Silverman ◽

David R. Gastfriend

Keyword(s):

Opioid Dependence ◽

Extended Release ◽

Healthcare Professionals ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text